Court, Explained
U.S. Federal District Courts
Back to docket
N.D. Cal.MixedFiled May 4, 2020

Racies v. Quincy Bioscience, LLC

Judge
Haywood Gilliam
Docket
4:15-cv-00292
Court
U.S. District Court · Northern District of California
Pages
12
Class ActionCivil ProcedureEvidence
In one sentence

In Racies v. Quincy Bioscience, Judge Gilliam decertified the consumer class and denied both sides’ requests for judgment as a matter of law.

Who this affects

Phillip Racies, Quincy Bioscience, LLC, and the California consumers who had been included in the certified class.

What happened

Racies v. Quincy Bioscience, LLC is a consumer lawsuit alleging that Quincy made misleading claims about its Prevagen brain-health supplement. The court had previously certified a class of California consumers who bought certain Prevagen products, but a jury later could not reach a unanimous verdict, so the court declared a mistrial.

The court found that trial evidence did not show that Phillip Racies saw and relied on the same statements as the certified class. His receipt identified a product labeled “Brain Cell Protection,” while he could not say whether the bottle he bought carried the “Improves Memory” statement. The court therefore found that the class did not satisfy requirements concerning the representative plaintiff’s typicality and the predominance of common issues.

Judge Haywood S. Gilliam, Jr. granted Quincy’s motion to decertify the class, denied Quincy’s motion for judgment as a matter of law on Racies’s individual claim, and denied Racies’s motion for judgment as a matter of law. The court scheduled a telephone conference to discuss how to finally resolve the case.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Racies v. Quincy Bioscience, LLC · No. 4:15-cv-00292
Judge
Haywood Gilliam
Date
May 4, 2020

Background

Phillip Racies brought claims under California’s Unfair Competition Law and Consumers Legal Remedies Act, alleging that Quincy Bioscience, LLC made false, misleading, and deceptive statements about Prevagen. The challenged statements included claims that Prevagen “improves memory” and supports “healthy brain function, sharper mind, and clearer thinking.”

In December 2017, the court certified a class consisting of California consumers who purchased certain Prevagen products during the applicable limitations period. At trial, Racies testified that he bought Prevagen because of memory and recall concerns and because of what he believed the product’s packaging said. His receipt showed a purchase described as “Prevagen Brn Cell Protect” for $27.99, and the trial evidence included a product labeled “Brain Cell Protection.” That label did not include the “Improves Memory” statement. Racies could not say whether the bottle he purchased carried the “Improves Memory” label or the “Brain Cell Protection” label.

A jury was unable to reach a unanimous verdict. The court declared a mistrial and then considered Quincy’s motion to decertify the class and both parties’ motions for judgment as a matter of law.

Motion to Decertify the Class

The court granted Quincy’s motion to decertify the class. Class decertification removes the case from class-action treatment when the requirements for maintaining a class are no longer met. The court explained that class-certification requirements must be reconsidered in light of the evidence developed at trial, and that Racies retained the burden of showing that those requirements were satisfied.

The court concluded that Racies’s claim was not typical of the class because the trial evidence did not establish that he saw and relied on the statements that formed the basis for class certification. The only product label admitted at trial was the “Brain Cell Protection” label, which made different statements from the “Improves Memory” label. Racies’s testimony about what he remembered seeing was vague, and he acknowledged that he could not honestly say which label appeared on the product he bought.

The court also held that common issues did not predominate. Reliance—showing that a defendant’s statement was an immediate cause of a consumer’s purchase or other injury—was an essential element of both the Unfair Competition Law and Consumers Legal Remedies Act claims. At the class-certification stage, the court had allowed a presumption that class members relied on the challenged statements because it understood those statements to have appeared on the products. After trial, however, Racies’s inability to identify whether he saw those statements meant that reliance could not be shown on a common classwide basis.

The court stated that the class also failed the adequacy requirement, which concerns whether the class representative and counsel can fairly and adequately protect the class’s interests. Its conclusion was that Racies failed to satisfy the typicality, adequacy, and predominance requirements under Federal Rule of Civil Procedure 23.

Motions for Judgment as a Matter of Law

The court denied Quincy’s motion for judgment as a matter of law on Racies’s individual claim. Judgment as a matter of law is appropriate only when the trial evidence permits only one reasonable conclusion and no reasonable juror could find for the opposing party. Although the court described Racies’s trial evidence as weak, it found that questions remained about what product he bought, the circumstances of the purchase, and what the label said. The court also found that Racies had introduced evidence of his own damages, including the receipt, which was sufficient after the class was decertified.

The court also denied Racies’s motion for judgment as a matter of law. Viewing the evidence in Quincy’s favor, the court found that the evidence did not compel the conclusion that any representation was false or that Prevagen did not work as represented.

Disposition

The court granted Defendant’s motion to decertify the class, denied Defendant’s motion for judgment as a matter of law, and denied Plaintiff’s motion for judgment as a matter of law. It set a telephone case-management conference for May 12, 2020, to discuss a plan for finally resolving the case.

The authoritative version

Read the full 12-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.